Laser, phaco workstation offer efficient cataract removal
February 1st 2002Salt Lake City-The Photon Laser and Phaco Workstation (Paradigm Medical Industries, Salt Lake City) lets surgeons use either laser or ultrasound to remove a cataract, with the ability of switching back and forth between the two modalities.
Power modulation upgrade takes phaco to new level
February 1st 2002New Orleans-WhiteStar, the new power modulation technology for the Sovereign System (Allergan), affords phacoemulsification surgeons improved intraoperative control and optimizes outcomes for patients, with clearer corneas on postoperative day 1, said Lisa Brothers Arbisser, MD, at the annual meeting of the American Academy of Ophthalmology here last fall.
Phacoemulsification technology tailored to nuclear hardness
February 1st 2002Editor's Note: James A. Davison, MD, is associate clinical professor, department of ophthalmology, University of Utah, Salt Lake City. His practice is the Wolfe Clinic, Marshalltown, IA. He discusses his cataract technique with Ophthalmology Times Senior Editor Julia Talsma.
Orbital presentations of giant cell arteritis unusual
January 1st 2002Inflammatory signs of the orbit (e.g., proptosis, chemosis, injection) are rarely the presenting findings in giant cell arteritis (GCA). These patients may be misdiagnosed as having orbital inflammatory pseudotumor when the process is really an underlying orbital ischemic or orbital infarction syndrome.
New technology lessens risk of wound burn during phaco
January 1st 2002Editor's Note: Randall J. Olson, MD, is the John A. Moran presidential professor and chair of ophthalmology, and director of the John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City. He recently spoke with Ophthalmology Times on his approach to cataract surgery.
Future of Cataract Surgery Relies on Refractive Lens Exchange
November 15th 2001Ophthalmologists continue to be concerned about decreasing reimbursement for cataract surgery and the increasing nonreimbursed costs of utilizing new technology. I believe, however, that the future for lens and implant surgery is rosy.
Retinal Prosthesis May do Work of Photoreceptor Cells
November 15th 2001Houston-An artificial retina could be the answer for an estimated 1 million Americans with retinal blindness by conditions such as retinitis pigmentosa and age-related macular degeneration, said Alex Ignatiev, PhD, professor of physics, chemistry, and electrical and computer engineering at the University of Houston.
Purite May be Gentler Preservative for Lubrication Solutions
November 1st 2001Almost all ophthalmic medications contain preservatives, which inhibit bacterial growth. The use of preservatives allows for the use of multidose bottles, which are the most cost-effective and user-friendly packaging for ophthalmic medications. However, some of the preservatives present in commonly used eye drops today have been shown to be disruptive to the cornea surface.1-5
Ophthalmologists 'Made a Difference' in Nation's Time of Need
November 1st 2001he American Academy ofOphthalmology and its members are to be commended for the immediate response to the need at New York's World Trade Center tragedy of Sept. 11. We have heard from many physicians who volunteered their services both at ground zero and emergency rooms in the area. Their stories have unified us and made us proud to be Americans. We will be hearing stories of selfless acts for months, perhaps years. They, and all the groups who volunteered their services, deserve all the praise and recognition they have received.
Standardization Called the Key to Improving LASIK Safety
November 1st 2001Overland Park, KS-Taking small, specific precautions throughout LASIK and adhering to proven techniques should help refractive surgeons eliminate most flap and other complications while improving visual outcomes, according to Dan Durrie, MD.
How to Manage Epithelial Ingrowth and Implantation
November 1st 2001Epithelial ingrowth is the migration of epithelial cells from outside the flap-bed interface into the interface postoperatively. Epithelial implantation is the placement of epithelial cells into the interface during the procedure. The incidence of epithelial ingrowth and implantation has been reported as high as 10%, although it can be as low as 0.2%1 to 0.4%2 if meticulous surgical technique is employed.
Treatment of pseudotumor cerebri reviewed
October 1st 2001Surgical maneuvers used to treat pseudotumor cerebri include some formof shunt procedure, such as a lumboperitoneal shunt, a ventriculoperitonealshunt, or optic nerve sheath decompression (ONSD). Shunting procedures areultimately designed to divert the cerebrospinal fluid (CSF) that is underpressure away from the neuro-ocular junction, where hydrodynamic forcescompress ganglion cells and their blood supply, leading to injury and/ordeath of these cells.
Web conferencing brings the world to your computer
October 1st 2001Most ophthalmologists agree that the Internet is a valuable resourcefor provider education. In addition to e-mail, physicians probably mostfrequently use the Internet to access information on diseases and medications.Increasingly they are also using it to access major medical journals andonline continuing medical education programs.